Functional effects of CD79B overexpression were examined in HL-60 cells, and gene set enrichment and immune-infiltration analyses were used to explore CD79B-associated pathways.<h4>Results</h4>CD79B expression was consistently reduced in MDS and AML compared with normal controls in public datasets and clinical samples. The gene discussed is CD79B; the disease is myelodysplastic syndrome.